Global Technologies launches Primecare Supply, signs revenue share and licensing deals

GLOBAL TECHNOLOGIES LTD

Wholly owned subsidiary Primecare Supply commenced sales operations on May 29, 2025.
Revenue Share Agreement with pharmaceutical supplier: Primecare retains 75% of gross margin above floor price; 3-year continuation right.
Master Licensing Agreement with AI tech firm: 24-month term, 2.5% platform fee on transactions.
Primecare targets medical spa, wellness clinic, and IV therapy markets with FDA-compliant protocols.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.